Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank25
3Y CAGR-79.1%
5Y CAGR-2.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-79.1%/yr
Annual compound
5Y CAGR
-2.7%/yr
Recent deceleration
Percentile
P25
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00 | -85.3% |
| 2023 | 0.03 | -95.7% |
| 2022 | 0.60 | +43.9% |
| 2021 | 0.42 | +4166.3% |
| 2020 | 0.01 | +125.6% |
| 2019 | 0.00 | -98.0% |
| 2018 | 0.22 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 0.41 | +58.9% |
| 2015 | 0.26 | - |